Research programme: viral vaccines - Spotlight Innovation

Drug Profile

Research programme: viral vaccines - Spotlight Innovation

Alternative Names: Immunoplex™ Ebola; Immunoplex™ HA flu; Immunoplex™ HepB

Latest Information Update: 13 Oct 2016

Price : $50

At a glance

  • Originator Memcine Pharmaceuticals
  • Developer Spotlight Innovation
  • Class Hepatitis B vaccines; Influenza virus vaccines; Peptide vaccines; Viral vaccines
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Ebola virus infections; Hepatitis B; Influenza virus infections

Most Recent Events

  • 07 Oct 2016 Discontinued - Preclinical for Hepatitis B (Prevention) in USA (unspecified route)
  • 07 Oct 2016 Discontinued - Preclinical for Influenza virus infections (Prevention) in USA (unspecified route)
  • 07 Oct 2016 Discontinued for Ebola virus infections (Prevention) in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top